ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.
Allorge
D
D
Hamdan
R
R
Broly
F
F
Libersa
C
C
Colombel
J-F
JF
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001379:Azathioprine / Q000009:adverse effects*; D003424:Crohn Disease / Q000235:genetics*; D004359:Drug Therapy, Combination; D020022:Genetic Predisposition to Disease; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007970:Leukopenia / Q000139:chemically induced; D015122:Mercaptopurine / Q000009:adverse effects*; D011755:Pyrophosphatases / Q000235:genetics*; D000097630:Inosine Triphosphatase
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001379:Azathioprine; D007166:Immunosuppressive Agents; D015122:Mercaptopurine; D011755:Pyrophosphatases; D000097630:Inosine Triphosphatase